PetIQ, Inc. Reports Second Quarter 2018 Financial Results
Second Quarter Net Sales Increase 96% Year-Over-Year to
Opened 20 Wellness Centers Year-to-Date
Company Raises Net Sales Outlook for Full Year 2018
Second Quarter 2018 Highlights Compared to Prior Year Period
- Net sales of
$171.1 million , an increase of 96% - Net income of
$5.4 million - Adjusted EBITDA of
$15.8 million compared to$7.6 million - Opened 17 wellness centers and three regional offices during the quarter, for a total of 29 wellness centers and 34 regional offices in operation as of quarter-end with all 20 VetIQ wellness centers currently open
- Liquidity of
$63 million at quarter end giving pro forma effect to$25 million accordion feature on revolving credit facility - Antitrust complaint filed against
PetIQ byMed Vets Inc. dismissed
Cord Christensen, PetIQ’s Chairman and Chief Executive Officer commented, “Our strong, broad-based growth continued during the second quarter resulting in record net sales. Our team expanded PetIQ’s pet preventative and wellness veterinarian products and services offerings to further our mission to make pets’ lives better with more affordable and accessible veterinarian services and products. We are very pleased with the progress of our “Follow the Pets” growth initiatives including the opening of 17 wellness center locations in the second quarter, with all 20 VetIQ wellness centers completed. Based on these strong operational and financial results as well as our outlook for the remainder of the year, we are raising our annual net sales guidance to
Second Quarter 2018 Financial Results
Net sales increased 96% to
Gross profit was
Net income was
Second quarter adjusted EBITDA was
Adjusted gross profit, adjusted net income, and adjusted EBITDA are non-GAAP financial measures. Beginning second quarter 2018, the Company is providing additional non-GAAP financial measures. The Company believes these non-GAAP financial information provides investors with additional insight into and measurement of its recent entry into the veterinary services business following the acquisition of VIP Petcare (“VIP”) in January 2018. In the Service segment, management has begun providing a “same-store sales” to reflect revenue for veterinary clinics open for four trailing quarters. Management believes this will provide useful information to investors as these veterinary retail service units mature and move into the comparable store base. See “Non-GAAP Measures” for a definition of these measures and the financial tables that accompany this release for a reconciliation to the most comparable GAAP measure.
First Half of Fiscal 2018 Highlights Compared to Prior Year Period
- Net sales of
$286.2 million , an increase of 86% - Net income of
$1.4 million - Adjusted EBITDA of
$21.4 million compared to$13.4 million
Net sales increased 86% to
Gross profit was
Net income was
For the first six months of 2018 adjusted EBITDA was
Adjusted gross profit, adjusted net income, and adjusted EBITDA are Non-GAAP financial measures. See “Non-GAAP Measures” for a definition of these measures and the financial tables that accompany this release for a reconciliation to the most comparable GAAP measure.
2018 Outlook
For full year 2018, the Company raised its net sales outlook and reiterated its adjusted EBITDA outlook compared to the prior year. The Company now expects the following results for the year ending
- Consolidated net sales of approximately
$500 million , an increase of approximately 88% year-over-year - Adjusted EBITDA of
$40 million to $45 million , an increase of 79% to 102% year-over-year*
*The Company does not provide guidance for the most directly comparable GAAP measure, net income, and similarly cannot provide a reconciliation between its forecasted adjusted EBITDA and net income metrics without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within the Company’s control and may vary greatly between periods and could significantly impact future financial results.
Segment Review
Products: For the second quarter of 2018, Product segment net sales increased 71% to
For the six months ended
Services: For the second quarter of 2018, Service segment net revenues and operating income were
For the six months ended
Cash and Debt
The Company increased liquidity on a pro forma basis to
As of
Conference Call and Webcast
The Company will host a conference call and webcast where members of the executive management team will discuss these results with additional comments and details today,
A replay of the conference call will be archived on the Company’s website and telephonic playback will be available from
About
Forward Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could" and similar expressions. Forward-looking statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances, or achievements expressed or implied by the forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, our ability to grow our business through acquisitions; our ability to integrate, manage and expand VIP’s business; our dependency on a limited number of customers; our ability to implement our growth strategy effectively; our ability to achieve or sustain profitability; our ability to open retail clinics and wellness centers, failure to effectively execute on our services segment rationalization plans; competition from veterinarians and others in our industry; reputational damage to our brands; economic trends and spending on pets; the effectiveness of our marketing and trade promotion programs; recalls or withdrawals of our products or product liability claims; our ability to manage our manufacturing and supply chain effectively; disruptions in our manufacturing and distribution chains; our ability to introduce new products and improve existing products; our failure to protect our intellectual property; costs associated with governmental regulation; risks related to our international operations; our ability to keep and retain key employees; and the risks set forth under the “Risk Factors” of our Annual Report on Form 10-K for the year ended
Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results. The forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Consequently, you should not place undue reliance on forward-looking statements.
Non-GAAP Financial Measures
In addition to financial results reported in accordance with U.S. GAAP,
Adjusted net income consists of GAAP Net income (loss) adjusted for tax expense, costs to become a public company, acquisitions expenses, purchase accounting adjustments, integration costs and costs of discontinued clinics, new clinic launch expense, and stock based compensation expense. Adjusted Net Income is utilized by management: (i) to compare operations of the Company prior to our initial public offering and (ii) to evaluate the effectiveness of our business strategies.
Adjusted gross profit consists of GAAP gross profit adjusted for purchase accounting adjustments, gross profit (loss) on clinics and wellness centers that are not part of same store sales, and new clinic launch expense. Adjusted gross profit is utilized by management to evaluate the effectiveness of our business strategies.
EBITDA represents net income (loss) before interest, income taxes, and depreciation and amortization. Adjusted EBITDA represents EBITDA plus management fees, stock based compensation expense, acquisition expenses, purchase accounting adjustments, fair value adjustments to contingent notes, integration costs and costs of discontinued clinics, loss on clinics and wellness centers that are not part of the same store sales, and new clinic launch expense. Adjusted EBITDA adjusts for transactions that management does not believe are representative of our core ongoing business. Adjusted EBITDA Margin is Adjusted EBITDA stated as a percentage of Net sales. Adjusted EBITDA is utilized by management: (i) as a factor in evaluating management's performance when determining incentive compensation and (ii) to evaluate the effectiveness of our business strategies. The Company presents EBITDA because it is a necessary component for computing Adjusted EBITDA.
The Company considers its same-store portfolio to consist of only those retail service regional offices and wellness centers that have been operating for four trailing quarters. The Company believes that same-store results are useful to investors in evaluating our performance because they provide information relating to changes in operating performance without taking into account the effects of new regional offices and wellness center development.
We believe that the use of Adjusted Net income, adjusted gross profit, and Adjusted EBITDA provide additional tools for investors to use in evaluating ongoing operating results and trends. In addition, you should be aware when evaluating Adjusted Net Income, adjusted gross profit, and Adjusted EBITDA, that in the future we may incur expenses similar to those excluded when calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by these or other unusual or non-recurring items. Our computation of Adjusted Net Income, adjusted gross profit and Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies do not calculate Adjusted Net Income, adjusted gross profit and Adjusted EBITDA in the same manner. Our management does not, and you should not, consider Adjusted Net Income, adjusted gross profit or Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted Net Income, adjusted gross profit and Adjusted EBITDA is that they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements. See a reconciliation of Non-GAAP measures to the most comparable GAAP measure, in the financial tables that accompany this release.
Definitions
- Mobile community clinic
- A mobile community clinic is defined as an event, or a visit to a retail partner location, by the Company’s veterinary staff utilizing the Company’s mobile service vehicles. Clinic locations and schedules vary by location and seasonally. Due to the non-standardization of the Company’s mobile community clinics, these clinics are grouped as part of geographic regions. New regions are excluded from the same store sale calculation until they have four full consecutive quarters of operations.
- A mobile community clinic is defined as an event, or a visit to a retail partner location, by the Company’s veterinary staff utilizing the Company’s mobile service vehicles. Clinic locations and schedules vary by location and seasonally. Due to the non-standardization of the Company’s mobile community clinics, these clinics are grouped as part of geographic regions. New regions are excluded from the same store sale calculation until they have four full consecutive quarters of operations.
- Wellness center
- A wellness center is a physical fixed service location within the existing footprint of one of our retail partners. These wellness centers operate under a variety of brands based on the needs of our partner locations, including the recently launched VetIQ clinics at
Walmart .
- A wellness center is a physical fixed service location within the existing footprint of one of our retail partners. These wellness centers operate under a variety of brands based on the needs of our partner locations, including the recently launched VetIQ clinics at
- Regional offices
- Regional offices support the operations of the Company’s services segment which include its mobile community clinics and wellness centers. These offices are staffed with field management and other operational staff.
CONTACT:
Investor Relations Contact: | Media Relations Contact: |
Katie Turner | Cory Ziskind |
ICR | ICR |
646-277-1228 | 646-277-1232 |
katie.turner@icrinc.com | cory.ziskind@icrinc.com |
PetIQ, Inc. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited, $’s in 000’s except for share and per share amounts) | ||||||||
June 30, 2018 | December 31, 2017 | |||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 11,672 | $ | 37,896 | ||||
Accounts receivable, net | 50,910 | 21,759 | ||||||
Inventories | 81,208 | 44,056 | ||||||
Supplier prepayments | 1,692 | 3,173 | ||||||
Other current assets | 1,967 | 1,991 | ||||||
Total current assets | 147,449 | 108,875 | ||||||
Property, plant and equipment, net | 25,833 | 15,000 | ||||||
Deferred tax assets | 18,595 | 5,994 | ||||||
Other non-current assets | 2,933 | 2,646 | ||||||
Intangible assets, net | 86,714 | 3,266 | ||||||
Goodwill | 118,335 | 5,064 | ||||||
Total assets | $ | 399,859 | $ | 140,845 | ||||
Liabilities and equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 65,291 | $ | 14,234 | ||||
Accrued wages payable | 3,423 | 1,811 | ||||||
Accrued interest payable | 926 | 115 | ||||||
Other accrued expenses | 2,225 | 1,880 | ||||||
Current portion of long-term debt and capital leases | 2,033 | 151 | ||||||
Total current liabilities | 73,898 | 18,191 | ||||||
Long-term debt | 107,404 | 17,183 | ||||||
Capital leases, less current installments | 1,646 | 389 | ||||||
Contingent notes | 7,500 | — | ||||||
Other non-current liabilities | 403 | 238 | ||||||
Total non-current liabilities | 116,953 | 17,810 | ||||||
Commitments and contingencies | ||||||||
Equity | ||||||||
Additional paid-in capital | 146,054 | 70,873 | ||||||
Class A common stock, par value $0.001 per share, 125,000,000 shares authorized, 16,647,998 and 13,222,583 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively |
16 | 13 | ||||||
Class B common stock, par value $0.001 per share, 100,000,000 shares authorized, 9,042,773 and 8,268,188 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively |
9 | 8 | ||||||
Accumulated deficit | (3,197 | ) | (3,493 | ) | ||||
Accumulated other comprehensive loss | (913 | ) | (687 | ) | ||||
Total stockholders' equity | 141,969 | 66,714 | ||||||
Non-controlling interest | 67,039 | 38,130 | ||||||
Total equity | 209,008 | 104,844 | ||||||
Total liabilities and equity | $ | 399,859 | $ | 140,845 | ||||
PetIQ, Inc. | ||||||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||||||
(Unaudited, $’s in 000’s, except for per share amounts) | ||||||||||||||||
For the three months ended | For the six months ended | |||||||||||||||
June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | |||||||||||||
Product sales | $ | 148,713 | $ | 87,178 | $ | 246,564 | $ | 154,207 | ||||||||
Services revenue | 22,429 | — | 39,644 | — | ||||||||||||
Total net sales | 171,142 | 87,178 | 286,208 | 154,207 | ||||||||||||
Cost of products sold | 127,583 | 71,227 | 212,169 | 126,056 | ||||||||||||
Cost of services | 17,241 | — | 31,838 | — | ||||||||||||
Total cost of sales | 144,824 | 71,227 | 244,007 | 126,056 | ||||||||||||
Gross profit | 26,318 | 15,951 | 42,201 | 28,151 | ||||||||||||
Operating expenses | ||||||||||||||||
General and administrative expenses | 16,943 | 9,277 | 35,911 | 16,682 | ||||||||||||
Operating income | 9,375 | 6,674 | 6,290 | 11,469 | ||||||||||||
Interest expense, net | (2,216 | ) | (535 | ) | (3,981 | ) | (999 | ) | ||||||||
Foreign currency gain (loss), net | 136 | (72 | ) | 58 | (121 | ) | ||||||||||
Other (expense) income, net | (877 | ) | 3 | (973 | ) | — | ||||||||||
Total other expense, net | (2,957 | ) | (604 | ) | (4,896 | ) | (1,120 | ) | ||||||||
Pretax net income | 6,418 | 6,070 | 1,394 | 10,349 | ||||||||||||
Income tax (expense) benefit | (1,020 | ) | — | 47 | — | |||||||||||
Net income | 5,398 | 6,070 | 1,441 | 10,349 | ||||||||||||
Net income attributable to non-controlling interest | 2,899 | 6,070 | 970 | 10,349 | ||||||||||||
Net income attributable to PetIQ, Inc. | $ | 2,499 | $ | — | $ | 471 | $ | — | ||||||||
Net income per share attributable to PetIQ, Inc. Class A common stock(1) |
||||||||||||||||
Basic | $ | 0.16 | — | $ | 0.03 | — | ||||||||||
Diluted | $ | 0.16 | — | $ | 0.03 | — | ||||||||||
Weighted average shares of Class A common stock outstanding(1) |
||||||||||||||||
Basic | 15,980,111 | — | 15,285,138 | — | ||||||||||||
Diluted | 16,008,046 | — | 15,328,596 | — | ||||||||||||
(1) | Basic and Diluted earnings per share is applicable only for periods after the Company’s IPO in July 2017. |
PetIQ, Inc. | |||||||
Condensed Consolidated Statements of Cash Flows | |||||||
(Unaudited, $’s in 000’s) | |||||||
For the six months ended | |||||||
June 30, 2018 | June 30, 2017 | ||||||
Cash flows from operating activities | |||||||
Net income | $ | 1,441 | $ | 10,349 | |||
Adjustments to reconcile net income to net cash (used in) operating activities | |||||||
Depreciation and amortization of intangible assets and loan fees | 5,714 | 1,687 | |||||
Foreign exchange (gain) loss on liabilities | (41 | ) | 14 | ||||
(Gain) loss on disposition of property | (49 | ) | 149 | ||||
Stock based compensation expense | 1,454 | — | |||||
Deferred tax adjustment | (47 | ) | — | ||||
Other non-cash activity | 266 | — | |||||
Changes in assets and liabilities | |||||||
Accounts receivable | (20,820 | ) | (14,175 | ) | |||
Inventories | (29,384 | ) | (8,473 | ) | |||
Prepaid expenses and other assets | 2,080 | (574 | ) | ||||
Accounts payable | 31,859 | 3,603 | |||||
Accrued wages payable | 410 | 377 | |||||
Other accrued expenses | (2,304 | ) | 54 | ||||
Net cash used in operating activities | (9,421 | ) | (6,989 | ) | |||
Cash flows from investing activities | |||||||
Proceeds from disposition of property, plant, and equipment | 103 | — | |||||
Purchase of property, plant, and equipment | (4,732 | ) | (681 | ) | |||
Business acquisition (net of cash acquired) | (92,083 | ) | — | ||||
Net cash used in investing activities | (96,712 | ) | (681 | ) | |||
Cash flows from financing activities | |||||||
Proceeds from issuance of long-term debt | 299,078 | 150,000 | |||||
Principal payments on long-term debt | (215,964 | ) | (141,962 | ) | |||
Principal payments on capital lease obligations | (561 | ) | (56 | ) | |||
Payment of deferred financing fees and debt discount | (2,613 | ) | (25 | ) | |||
Net cash provided by financing activities | 79,940 | 7,957 | |||||
Net change in cash and cash equivalents | (26,193 | ) | 287 | ||||
Effect of exchange rate changes on cash and cash equivalents | (31 | ) | (6 | ) | |||
Cash and cash equivalents, beginning of period | 37,896 | 767 | |||||
Cash and cash equivalents, end of period | $ | 11,672 | $ | 1,048 | |||
PetIQ, Inc. | |||||||||||
Reconciliation between gross profit and adjusted gross profit | |||||||||||
(Unaudited, $’s in 000’s) | |||||||||||
For the three months ended | For the six months ended | ||||||||||
June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | ||||||||
Gross profit | $ | 26,318 | $ | 15,951 | $ | 42,201 | $ | 28,151 | |||
Plus: | |||||||||||
Purchase accounting adjustment to inventory | — | — | 1,502 | — | |||||||
Non same-store gross profit | 917 | — | 1,084 | — | |||||||
Clinic launch expense | 846 | — | 1,211 | — | |||||||
Adjusted gross profit | $ | 28,081 | $ | 15,951 | $ | 45,998 | $ | 28,151 | |||
PetIQ, Inc. | ||||||||||||||
Reconciliation between Net Income and Adjusted EBITDA | ||||||||||||||
(Unaudited, $’s in 000’s) | ||||||||||||||
For the three months ended | For the six months ended | |||||||||||||
June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | |||||||||||
Net income | $ | 5,398 | $ | 6,070 | $ | 1,441 | $ | 10,349 | ||||||
Plus: | ||||||||||||||
Tax expense (benefit) | 1,020 | — | (47 | ) | — | |||||||||
Depreciation | 1,780 | 575 | 3,030 | 1,111 | ||||||||||
Amortization | 1,257 | 261 | 2,397 | 521 | ||||||||||
Interest | 2,216 | 535 | 3,981 | 999 | ||||||||||
EBITDA | $ | 11,671 | $ | 7,441 | $ | 10,802 | $ | 12,980 | ||||||
Acquisition costs(1) | 151 | — | 3,366 | — | ||||||||||
Management fees(2) | — | 196 | — | 386 | ||||||||||
Stock based compensation expense | 756 | — | 1,454 | — | ||||||||||
Purchase accounting adjustment to inventory | — | — | 1,502 | — | ||||||||||
Non same-store revenue(3) | (794 | ) | — | (1,015 | ) | — | ||||||||
Non same-store costs(3) | 1,903 | — | 2,291 | — | ||||||||||
Fair value adjustment of contingent note | 459 | — | 600 | — | ||||||||||
Integration costs and costs of discontinued clinics | 385 | — | 756 | — | ||||||||||
New wellness center launch expenses(4) | 846 | — | 1,211 | — | ||||||||||
Non-recurring royalty settlement(5) | 440 | — | 440 | — | ||||||||||
Adjusted EBITDA | $ | 15,817 | $ | 7,637 | $ | 21,407 | $ | 13,366 | ||||||
(1) | Acquisition costs relating to our acquisition of VIP, which was completed during the six months ended June 30, 2018. |
(2) | Represents annual fees paid pursuant to our management agreements with Eos, Highland and Labore. The management agreements terminated in connection with our IPO in July 2017. |
(3) | Non same-store revenue and costs are from wellness centers and regions with less than four full trailing quarters of operating results. There were 23 wellness centers and 5 regions that had less than four trailing quarters of operating results for the three and six months ended June 30, 2018 and non for the three and six months ended June 30, 2017. |
(4) | Clinic launch expenses represent the nonrecurring costs to open new veterinary wellness centers, primarily employee costs, training, marketing, and rent prior to opening for business. |
(5) | Represents a settlement paid to a supplier related to a royalty agreement in place since 2013. |
PetIQ, Inc. | |||||||||||||||
Reconciliation between Net Income and Adjusted Net Income | |||||||||||||||
(Unaudited, $’s in 000’s) | |||||||||||||||
Three months ended | Six months ended | ||||||||||||||
June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | ||||||||||||
Net income | $ | 5,398 | $ | 6,070 | $ | 1,441 | $ | 10,349 | |||||||
Plus: | |||||||||||||||
Acquisition costs(1) | 151 | — | 3,366 | — | |||||||||||
Tax expense | 1,020 | — | (47 | ) | — | ||||||||||
Stock based compensation expense | 756 | — | 1,454 | — | |||||||||||
Purchase accounting adjustment to inventory | — | — | 1,502 | — | |||||||||||
Non same-store revenue(3) | (794 | ) | — | (1,015 | ) | — | |||||||||
Non same-store costs(3) | 1,903 | — | 2,291 | — | |||||||||||
Fair value adjustment of contingent note | 459 | — | 600 | — | |||||||||||
Integration costs and costs of discontinued clinics | 385 | — | 756 | — | |||||||||||
New clinic launch expenses(2) | 846 | — | 1,211 | — | |||||||||||
Non-recurring royalty settlement | 440 | — | 440 | — | |||||||||||
Adjusted Net income | $ | 10,564 | $ | 6,070 | $ | 11,999 | $ | 10,349 | |||||||
(1) | Acquisition costs relating to our acquisition of VIP, which was completed during the three months ended June 30, 2018. |
(2) | Clinic launch expenses represent the nonrecurring costs to open new veterinary wellness centers, primarily employee costs, training, marketing, and rent prior to opening for business. |
(3) | Non same-store revenue and costs are from wellness centers and regions with less than four full trailing quarters of operating results. |